Neumora Therapeutics, Inc. (NMRA)
$1.41-$0.07 (-4.83%) Today
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 11 | 453,833 | $702K |
| Grant or award | 5 | 1,750,000 | |
| Option exercise | 32 | 839,626 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
28 Form 4 filings on record, the earliest from Oct 11, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 21,685 | $0.72 | $16K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 45,026 | $0.72 | $32K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 67,741 | $0.72 | $49K | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 67,741 | $1.51 | $103K | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 66,711 | $1.51 | $101K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 20,553 | $0.72 | $15K | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 20,553 | $1.59 | $33K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 21,055 | $0.72 | $15K | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 21,055 | $1.60 | $34K | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 67,741 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 45,026 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 21,685 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Grant or award | Stock Option (Right to Buy) | 200,000 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 20,553 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 21,055 | $0.00 | - | |
| Paul L. Berns - Officer | Grant or award | Stock Option (Right to Buy) | 500,000 | $0.00 | - | |
| Jason Duncan - Officer | Grant or award | Stock Option (Right to Buy) | 375,000 | $0.00 | - | |
 Michael Lee Milligan - Officer | Grant or award | Stock Option (Right to Buy) | 175,000 | $0.00 | - | |
| Joshua Pinto - Officer | Grant or award | Stock Option (Right to Buy) | 500,000 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 40,890 | $0.72 | $29K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 15,355 | $0.72 | $11K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 1,424 | $0.72 | $1K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 1 | $0.72 | $1 | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 57,670 | $1.51 | $87K | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 34,020 | $1.49 | $51K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 25,279 | $0.72 | $18K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 29,737 | $0.72 | $21K | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 55,016 | $1.50 | $83K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 34,162 | $0.72 | $25K | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 34,162 | $1.58 | $54K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 34,987 | $0.72 | $25K | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 34,987 | $1.59 | $55K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 13,268 | $0.72 | $10K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 17,732 | $0.72 | $13K | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 31,000 | $1.65 | $51K | |
| Daljit Singh Aurora - Officer | Option exercise | Common Stock | 30,918 | $0.72 | $22K | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 30,918 | $1.65 | $51K | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 40,890 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 15,355 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 1,424 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 1 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 25,279 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 29,737 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 34,162 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 34,987 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 13,268 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 17,732 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Option exercise | Stock Option (Right to Buy) | 30,918 | $0.00 | - | |
| Kristina Burow | Grant or award | Stock Option (Right to Buy) | 80,000 | $0.00 | - | |
| Matthew K. Fust | Grant or award | Stock Option (Right to Buy) | 80,000 | $0.00 | - | |
 David Piacquad | Grant or award | Stock Option (Right to Buy) | 80,000 | $0.00 | - | |
| Alaa Halawa | Grant or award | Stock Option (Right to Buy) | 80,000 | $0.00 | - | |
 Maykin Ho | Grant or award | Stock Option (Right to Buy) | 80,000 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 6,165 | $3.56 | $22K | |
| Joshua Pinto - Officer | Open-market sale | Common Stock | 5,967 | $3.54 | $21K | |
| Paul L. Berns - Officer | Open-market sale | Common Stock | 9,819 | $3.51 | $34K | |
| Michael Lee Milligan - Officer | Open-market sale | Common Stock | 1,436 | $3.57 | $5K | |
| Michael Lee Milligan - Officer | Grant or award | Stock Option (Right to Buy) | 350,000 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Grant or award | Stock Option (Right to Buy) | 750,000 | $0.00 | - | |
| Jason Duncan - Officer | Grant or award | Stock Option (Right to Buy) | 750,000 | $0.00 | - | |
| Joshua Pinto - Officer | Grant or award | Stock Option (Right to Buy) | 1,200,000 | $0.00 | - | |
| Paul L. Berns - Officer | Grant or award | Stock Option (Right to Buy) | 1,650,000 | $0.00 | - | |
| Daljit Singh Aurora - Officer | Open-market sale | Common Stock | 114,703 | $2.68 | $307K | |
| ARCH Venture Partners X, LLC - 10% Owner | Open-market purchase | Common Stock | 1,915,700 | $2.61 | $5.00M | |
| Kristina Burow - Director | Open-market purchase | Common Stock | 1,915,700 | $2.61 | $5.00M | |
| ARCH Venture Partners XII, LLC - 10% Owner | Open-market purchase | Common Stock | 1,915,700 | $2.61 | $5.00M | |
| Paul L. Berns - Officer | Derivative | Stock Option (Right to Buy) | 497,049 | - | - | |
| Paul L. Berns - Officer | Derivative | Stock Option (Right to Buy) | 955,864 | - | - | |
| Paul L. Berns - Officer | Derivative | Stock Option (Right to Buy) | 342,500 | - | - | |
| Paul L. Berns - Officer | Derivative | Stock Option (Right to Buy) | 2,000,000 | - | - | |
| Paul L. Berns - Officer | Grant or award | Stock Option (Right to Buy) | 497,049 | - | - | |
| Paul L. Berns - Officer | Grant or award | Stock Option (Right to Buy) | 955,864 | - | - | |
| Paul L. Berns - Officer | Grant or award | Stock Option (Right to Buy) | 342,500 | - | - | |
| Paul L. Berns - Officer | Grant or award | Stock Option (Right to Buy) | 2,000,000 | - | - | |
| Paul L. Berns | Gift | Common Stock | 133,097 | $0.00 | - | |
| Paul L. Berns | Gift | Common Stock | 133,097 | $0.00 | - | |
| Paul L. Berns | Gift | Common Stock | 133,097 | $0.00 | - | |
| Matthew K. Fust | Option exercise | Common Stock | 3,783 | $8.32 | $31K | |
| Matthew K. Fust | Option exercise | Common Stock | 1,800 | $8.79 | $16K | |
| Matthew K. Fust | Option exercise | Common Stock | 2,156 | $2.52 | $5K | |
| Matthew K. Fust | Open-market sale | Common Stock | 7,739 | $17.01 | $132K | |
| Matthew K. Fust | Option exercise | Common Stock | 6,205 | $8.79 | $55K | |
| Matthew K. Fust | Option exercise | Common Stock | 7,844 | $2.52 | $20K | |
| Matthew K. Fust | Open-market sale | Common Stock | 14,049 | $17.03 | $239K | |
| Matthew K. Fust | Option exercise | Stock Option (Right to Buy) | 3,783 | $0.00 | - | |
| Matthew K. Fust | Option exercise | Stock Option (Right to Buy) | 1,800 | $0.00 | - | |
| Matthew K. Fust | Option exercise | Stock Option (Right to Buy) | 2,156 | $0.00 | - | |
| Matthew K. Fust | Option exercise | Stock Option (Right to Buy) | 6,205 | $0.00 | - | |
| Matthew K. Fust | Option exercise | Stock Option (Right to Buy) | 7,844 | $0.00 | - | |
| Robert A. Lenz - Officer | Open-market sale | Common Stock | 5,563 | $15.01 | $84K | |
| Robert A. Lenz - Officer | Open-market sale | Common Stock | 8,260 | $15.09 | $125K |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Aurora Daljit Singh | Officer | 41,608 | $66K | View on EDGAR | |
| Aurora Daljit Singh | Officer | 134,452 | $204K | View on EDGAR | |
| Aurora Daljit Singh | Officer | 61,918 | $102K | View on EDGAR |
Neumora Therapeutics, Inc. (NMRA) had 6 insider filings in the last 90 days, with the most recent on 2026-08-21. The full record for NMRA runs to 28 Form 4 filings, the earliest from 2024-10-11. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of NMRA were filed in the last 90 days. 3 purchases are on record for this company.
11 insider sales of NMRA were filed in the last 90 days, totaling $702K.
This page tracks NMRA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add NMRA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
